Sands Capital Alternatives as of June 30, 2026
Portfolio Holdings for Sands Capital Alternatives
Sands Capital Alternatives holds 24 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alamar Biosciences Common Stock | 18.7 | $115M | 4.2M | 27.09 | |
| Nu Hldgs Ord Shs Cl A (NU) | 15.4 | $95M | 7.1M | 13.36 | |
| Klaviyo Com Ser A (KVYO) | 9.7 | $59M | 3.9M | 15.10 | |
| Beta Bionics (BBNX) | 9.5 | $58M | 3.7M | 15.67 | |
| Spyglass Pharma Com Shs (SGP) | 9.1 | $56M | 2.5M | 22.26 | |
| Inhibikase Therapeutics Com New (IKT) | 4.3 | $26M | 13M | 2.03 | |
| Doordash Cl A (DASH) | 3.8 | $24M | 128k | 184.53 | |
| Coupang Cl A (CPNG) | 3.8 | $23M | 1.3M | 17.37 | |
| Datadog Cl A Com (DDOG) | 3.4 | $21M | 81k | 260.36 | |
| Bioage Labs (BIOA) | 3.1 | $19M | 786k | 24.51 | |
| 10x Genomics Cl A Com (TXG) | 3.0 | $19M | 482k | 38.34 | |
| Samsara Com Cl A (IOT) | 2.7 | $17M | 516k | 32.43 | |
| Odyssey Therapeutics Common Stock | 2.7 | $16M | 875k | 18.71 | |
| Toast Cl A (TOST) | 1.7 | $10M | 365k | 27.82 | |
| Acumen Pharmaceuticals (ABOS) | 1.6 | $9.9M | 3.7M | 2.67 | |
| Servicetitan Shs Cl A (TTAN) | 1.3 | $7.7M | 109k | 70.71 | |
| Cerebras Systems Com Cl A (CBRS) | 1.2 | $7.3M | 33k | 221.00 | |
| Snowflake Com Shs (SNOW) | 1.0 | $6.2M | 25k | 254.50 | |
| Monday SHS (MNDY) | 1.0 | $5.9M | 82k | 72.39 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $5.3M | 85k | 62.94 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.8 | $4.9M | 725k | 6.81 | |
| Candel Therapeutics (CADL) | 0.7 | $4.2M | 406k | 10.30 | |
| Acrivon Therapeutics Common Stock (ACRV) | 0.7 | $4.1M | 2.3M | 1.78 | |
| Figma Class A Com Stk (FIG) | 0.1 | $401k | 22k | 18.09 |
